Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29635035 | 1.00 | KIF11 (0.65) | KIF11DNMT1 | |
| SCHEMBL5996941 | 1.00 | KIF11 (0.65) | KIF11DNMT1 | |
| Hydrochloric Acid SCHEMBL25242234 | 0.99 | KIF11 (0.64) | KIF11DNMT1 | |
| Hydrochloric Acid SCHEMBL4459708 | 0.99 | KIF11 (0.64) | KIF11DNMT1 | |
| Hydrochloric Acid SCHEMBL4459715 | 0.99 | KIF11 (0.64) | KIF11DNMT1 | |
| SCHEMBL30745107 | 0.90 | KIF11 (0.64) | KIF11DNMT1 | |
| SCHEMBL8036028 | 0.89 | KIF11 (0.60) | KIF11DNMT1 | |
| SCHEMBL12872399 | 0.85 | KIF11 (0.85) | KIF11DNMT1 | |
| SCHEMBL3439368 | 0.85 | KIF11 (0.85) | KIF11DNMT1 | |
| SCHEMBL9137501 | 0.85 | KIF11 (0.85) | KIF11DNMT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250042939-A1 | PREPARATION METHOD FOR OXIDIZED GLUTATHIONE AND CRYSTAL FORM AND IMPURITY THEREOF | SHENYANG XINGQI PHARMACEUTICAL CO., LTD. (CN) | 2025-02-06 | — | — | US | claimed |
| EP-4455156-A1 | PREPARATION METHOD FOR OXIDIZED GLUTATHIONE AND CRYSTAL FORM AND IMPURITY THEREOF | Shenyang Xingqi Pharmaceutical Co., Ltd. (CN) | 2024-10-30 | — | — | EP | claimed |
| WO-2023116664-A1 | PREPARATION METHOD FOR OXIDIZED GLUTATHIONE AND CRYSTAL FORM AND IMPURITY THEREOF | 沈阳兴齐眼药股份有限公司 | 2023-06-29 | — | — | WO | claimed |
| EP-4306530-B1 | SILANE-CONTAINING CONDENSED CYCLIC DIPEPTIDE COMPOUND, PRODUCTION METHOD THEREFOR, AND METHOD FOR PRODUCING POLYPEPTIDE COMPOUND USING SAME | CHUBU UNIV EDUCATIONAL FOUNDATION (JP) | 2026-04-01 | — | — | EP | disclosed |
| US-20250326798-A1 | Synthetic Process for Production of Modified GCC Receptor Agonists | IRONWOOD PHARMACEUTICALS INC (US) | 2025-10-23 | — | — | US | disclosed |
| US-20250042939-A1 | PREPARATION METHOD FOR OXIDIZED GLUTATHIONE AND CRYSTAL FORM AND IMPURITY THEREOF | SHENYANG XINGQI PHARMACEUTICAL CO., LTD. (CN) | 2025-02-06 | — | — | US | disclosed |
| EP-4455156-A1 | PREPARATION METHOD FOR OXIDIZED GLUTATHIONE AND CRYSTAL FORM AND IMPURITY THEREOF | Shenyang Xingqi Pharmaceutical Co., Ltd. (CN) | 2024-10-30 | — | — | EP | disclosed |
| EP-4436980-A1 | SYNTHETIC PROCESS FOR PRODUCTION OF MODIFIED GCC RECEPTOR AGONISTS | Ironwood Pharmaceuticals, Inc. (US) | 2024-10-02 | — | — | EP | disclosed |
| CN-118591551-A | Synthetic methods for producing modified GCC receptor agonists | 硬木药品公司 | 2024-09-03 | — | — | CN | disclosed |
| US-20240209020-A1 | REACTION AGENT FOR AMIDE REACTION AND METHOD FOR PRODUCING AMIDE COMPOUND USING SAME | CHUBU UNIVERSITY EDUCATIONAL FOUNDATION (JP) | 2024-06-27 | — | — | US | disclosed |
| US-20240182517-A1 | SILANE-CONTAINING CONDENSED CYCLIC DIPEPTIDE COMPOUND, PRODUCTION METHOD THEREFOR, AND METHOD FOR PRODUCING POLYPEPTIDE COMPOUND USING SAME | CHUBU UNIVERSITY EDUCATIONAL FOUNDATION (JP) | 2024-06-06 | — | — | US | disclosed |
| WO-2022190486-A1 | SILANE-CONTAINING CONDENSED CYCLIC DIPEPTIDE COMPOUND, PRODUCTION METHOD THEREFOR, AND METHOD FOR PRODUCING POLYPEPTIDE COMPOUND USING SAME | 学校法人中部大学 | 2022-09-15 | — | — | WO | disclosed |
| EP-4053101-A1 | REACTION AGENT FOR AMIDE REACTION AND METHOD FOR PRODUCING AMIDE COMPOUND USING SAME | Chubu University Educational Foundation (JP) | 2022-09-07 | — | — | EP | disclosed |
| EP-3779449-B1 | DYNAMIC COMBINATORIAL LIBRARY BASED ON PSEUDOPEPTIDES AND ITS USE FOR THE DETECTION OF CYSTEINE AND OTHER BIOTHIOLS | CONSEJO SUPERIOR INVESTIGACION (ES) | 2022-02-23 | — | — | EP | disclosed |
| WO-2009151744-A1 | S-NITROSOMERCAPTO COMPOUNDS AND RELATED DERIVATIVES | GALLEON PHARMACEUTICALS, INC. (US) | 2009-12-17 | — | — | WO | disclosed |
| US-20060281926-A1 | Synthesis of 2-alkylcysteine via phase transfer catalysis | GIMI RAYOMAND H | 2006-12-14 | — | — | US | disclosed |
| US-7115769-B2 | Synthesis of 2-alkylcysteine via phase transfer catalysis | GENZYME CORPORATION (US) | 2006-10-03 | — | — | US | disclosed |
| EP-1529037-A2 | SYNTHESIS OF 2-ALKYLCYSTEINES, 2-(HYDROXYLATED PHENYL)-4-ALKYLTHIAZOLINE-4-CARBOXYLIC ACIDS AND DERIVATIVES THEREOF | Genzyme Corporation (US) | 2005-05-11 | — | — | EP | disclosed |
| US-20030236404-A1 | Synthesis of 2-alkylcysteine via phase transfer catalysis | GENZYME CORPORATION | 2003-12-25 | — | — | US | disclosed |
| WO-2003097622-A2 | SYNTHESIS OF 2-ALKYLCYSTEINES, 2-(HYDROXYLATED PHENYL)-4-ALKYLTHIAZOLINE-4-CARBOXYLIC ACIDS AND DERIVATIVES THEREOF | GENZYME CORPORATION (US) | 2003-11-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030236404-A1 | Synthesis of 2-alkylcysteine via phase transfer catalysis | DIMT1, ICMT, CNDP2 | KIF11 4699/4885DNMT1 1291/4885 |
| US-20250326798-A1 | Synthetic Process for Production of Modified GCC Receptor Agonists | GNRHR, SCTR, GIPR | KIF11 2319/4885DNMT1 4278/4885 |
| US-20250042939-A1 | PREPARATION METHOD FOR OXIDIZED GLUTATHIONE AND CRYSTAL FORM AND IMPURITY THEREOF | GPX4, GPX1, GSTM2 | KIF11 3253/4885DNMT1 1313/4885 |
| US-20240209020-A1 | REACTION AGENT FOR AMIDE REACTION AND METHOD FOR PRODUCING AMIDE COMPOUND USING SAME | NAAA, FAAH, FAAH2 | KIF11 2232/4885DNMT1 4185/4885 |
| US-20240182517-A1 | SILANE-CONTAINING CONDENSED CYCLIC DIPEPTIDE COMPOUND, PRODUCTION METHOD THEREFOR, AND METHOD FOR PRODUCING POLYPEPTIDE COMPOUND USING SAME | VIP, NGLY1, NPR1 | KIF11 347/4885DNMT1 2764/4885 |
| US-20060281926-A1 | Synthesis of 2-alkylcysteine via phase transfer catalysis | DIMT1, ICMT, CNDP2 | KIF11 4699/4885DNMT1 1291/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.